final program.qxd - Parallels Plesk Panel
final program.qxd - Parallels Plesk Panel
final program.qxd - Parallels Plesk Panel
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
POSTERS PRESENTATIONS - PRESENTATIONS POSTERS<br />
• PP 4.5<br />
• PP 4.6<br />
A Prospective Study of Antiretroviral Drug Adherence in HIV-Infected Patients<br />
in Oman<br />
SAID HAMED SAID AL DHAHRY, MUSCAT, OMN<br />
Impact of Free and Universal Access to Antiretroviral Treatment on the<br />
Survival among Brazilian Children with AIDS<br />
LUIZA HARUNARI MATIDA, SAO PAULO, BRA<br />
• PP 4.7 Telephone-Based Coping Improvement Group Intervention for Persons 50<br />
Years of Age or Older Living with HIV/AIDS in the United States<br />
TIMOTHY G. HECKMAN, ATHENS, USA<br />
• PP 4.8<br />
• PP 4.9<br />
Management of Nutrition-related Symptoms among People Living with<br />
HIV/AIDS under Antiretroviral Therapy<br />
ADAMA NDIR, DAKAR, SEN<br />
The Significantly Different Profile on Lipid Metabolism and its Correlates,<br />
caused by Efavirenz Compared with Nevirapine<br />
ROBERTO MANFREDI, BOLOGNA, ITA<br />
• PP 4.10 Evolution of HIV1 infected Patient ProfileTreated by Enfuvirtide (Fuzeon ® )<br />
ISABELLE POIZOT-MARTIN, MARSEILLE, FRA<br />
• PP 4.11<br />
• PP 4.12<br />
• PP 4.13<br />
• PP 4.14<br />
• PP 4.15<br />
• PP 4.16<br />
Self-evaluation Investigation of Patients Treated by Antiretroviral Therapy<br />
BÉNÉDICTE COUREAU, MARSEILLE, FRA<br />
Significant Modification of Administrative Re-imbursement Facilities of all<br />
Lipid-Lowering Drugs in Italy. No consideration of HIV-infected patients with<br />
HAART-related dyslipidemia, who loss their right to a re-imbursed access to<br />
statins, fibrates, and omega-3 derivatives<br />
ROBERTO MANFREDI, BOLOGNA, ITA<br />
Treatment of Kaposi's Sarcoma by Peginterferon alfa-2a<br />
JEAN-LUC DELASSUS, AULNAY SOUS BOIS, FRA<br />
Immune Markers of HIV Disease Progression are not Modified by long-term<br />
Statin Administration, when considering HIV-infected Dyslipidemic Patients<br />
Treated with a Steadily, Virologically Effective HAART regimen. A prospective<br />
study, controlled versus fibrate administration, or a dietary/exercise <strong>program</strong><br />
ROBERTO MANFREDI, BOLOGNA, ITA<br />
Pharmacokinetic Interaction Between the HIV Protease inhibitors TMC114<br />
and Indinavir, in the Presence of low-dose ritonavir<br />
VANITHA SEKAR, YARDLEY, USA<br />
Effects of Demographic Factors on Trough Lopinavir and Ritonavir Plasma<br />
Concentrations in HIV- infected Patients Treated with Kaletra<br />
JEAN-MARIE POIRIE, PARIS, FRA<br />
“ Focusing FIRST on PEOPLE “ 26 w w w . i s h e i d . c o m
Change language